TY - RPRT TI - Ascites in malignant ovarian cancer confer ovarian cancer cells chemoresistance to platinum. Combination treatment with crizotinib and 2-hydroxyestradiol restores platinum sensitivity. AU - Carmi, Y. K. AU - Agbarya, A. AU - Khamaisi, H. AU - Farah, R. AU - Shechtman, Y. AU - Korobochka, R. AU - Gopas, J. AU - Mahajna, J. PY - 2023 DO - 10.1101/2023.09.24.559160 UR - https://www.biorxiv.org/content/10.1101/2023.09.24.559160v1 ID - 10.1101/2023.09.24.559160 ER -